Elevated expression of lung development-related protein HSP90β indicates poor prognosis in non-small cell lung cancer through affecting the cell cycle and apoptosis-Reference-Cited by-同舟云学术

Elevated expression of lung development-related protein HSP90β indicates poor prognosis in non-small cell lung cancer through affecting the cell cycle and apoptosis

Published:2021-02-26 Issue:1 Volume:6 Page:
ISSN:2059-3635
Container-title:Signal Transduction and Targeted Therapy
language:en
Short-container-title:Sig Transduct Target Ther

Author:

Wang Xiang,Wang Yaru,Feng Lin,Wang Minghui,Zhang Kaitai,Mao Yousheng,Xiao Ting^ORCID,Cheng Shujun

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics

Link

http://www.nature.com/articles/s41392-021-00465-y.pdf

Reference5 articles.

1. Ma, Y. et al. The relationship between early embryo development and tumourigenesis. J. Cell Mol. Med. 14, 2697–2701 (2010).

2. Biao, R. et al. Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients. J. Exp. Clin. Cancer Res. 31, 70 (2012).

3. Xu, J. Y. et al. Integrative proteomic characterization of human lung adenocarcinoma. Cell 182, 245–261 (2020).

4. Yu, X. et al. Crosstalk of dynamic functional modules in lung development of rhesus macaques. Mol. BioSyst. 12, 1342–1349 (2016).

5. Feng, L. et al. Gene expression profiling in human lung development: an abundant resource for lung adenocarcinoma prognosis. PLoS ONE 9, e105639 (2014).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the lncMST-EPRS/HSP90AB1 complex as novel therapeutic strategy for T-2 toxin-induced growth retardation;Ecotoxicology and Environmental Safety;2022-12

2. E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90β and MAST1 to Repress Radiation Resistance in Non-Small-Cell Lung Cancer Stem Cells;Stem Cells International;2022-09-20

3. Four-protein model for predicting prognostic risk of lung cancer;Frontiers of Medicine;2022-03-09

4. Emerging genetic biomarkers in lung adenocarcinoma;SAGE Open Medicine;2022-01